XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.21.2

Equity and Earnings per Share (Tables) | 9 Months Ended
--- | ---
Oct. 30, 2021
Earnings Per Share [Abstract] |
Reconciliation of Number of Shares Outstanding for Basic and Diluted Earnings Per Share | The following table provides a reconciliation of the number of shares outstanding for basic and diluted earnings per share:
|  | For the three months ended |  |  | For the nine months ended |
|  | October 30, 2021 |  |  | October 31, 2020 |  |  | October 30, 2021 |  |  | October 31, 2020 |
(in thousands) |  |  |  |  |  |  |  |  |  |  |  |
Common stock outstanding: |  |  |  |  |  |  |  |  |  |  |  |
Basic weighted average common shares outstanding |  |  | 63,699 |  |  |  | 51,545 |  |  |  | 63,126 |  |  |  | 51,127 |
Common stock equivalents – stock options, restricted stock units and deferred stock (1) |  |  | 4,945 |  |  |  | — |  |  |  | 4,252 |  |  |  | — |
Diluted weighted average common shares outstanding |  |  | 68,644 |  |  |  | 51,545 |  |  |  | 67,378 |  |  |  | 51,127 |
Co mmon stock equivalents of 134 shares and 172 shares for the three and nine months ended October 31, 2020 were excluded due to the net loss.
Potential Common Stock Equivalents Excluded from Computation of Diluted Earnings Per Share | The following potential common stock equivalents were excluded from the computation of diluted earnings per share in each period because the exercise price of such options was greater than the average market price per share of common stock for the respective periods or because the unearned compensation associated with stock options, restricted stock units, or deferred stock had an anti-dilutive effect.
|  | For the three months ended |  |  | For the nine months ended |
|  | October 30, 2021 |  |  | October 31, 2020 |  |  | October 30, 2021 |  |  | October 31, 2020 |
(in thousands, except exercise prices) |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  |  | — |  |  |  | 3,676 |  |  |  | 386 |  |  |  | 3,676 |
Restricted stock units |  |  | — |  |  |  | 833 |  |  |  | — |  |  |  | 833 |
Deferred stock |  |  | — |  |  |  | 191 |  |  |  | — |  |  |  | 191 |
Range of exercise prices of such options |  |  | — |  |  | $0.53 - $7.02 |  |  | $4.19 - $5.50 |  |  | $0.53 - $7.02 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration